Evolv Hides Critical Details in NCS4 Results

By Donald Maye, Published Mar 23, 2022, 10:55am EDT (Info+)

Evolv is demanding NDAs to see the full NCS4 report, while NCS4 told IPVM Evolv required this claiming confidentiality.

IPVM Image

While NCS4 released a highly detailed report on PatriotOne, one of Evolv's main competitors, NCS4 was required to issue only a limited report on Evolv.

In this report, IPVM shares details about the public and restricted reports, why Evolv claims it took this approach, examines the notable missing details from the public Evolv report, NCS4’s response to our questions about the situation, and how this not only damages NCS4’s stated transparency aims, but also hurts the public.

Evolv *********** ********

********** ******** *** ****** *** ***** ** be ****** ** ********, *** *** publication *** ******* * ******. **** led ** ********* *********** *** *** reason ** *** *****. ******* ***** or ******** ******* ** *** *****, *******, our ************* ** **** **** *** driven ** *****'* ******* ** ******* what ** ***** ******** ********.

*** ****** ******* ** *****'* *********** exercise ******* **** ******** *********** * **-**** ***** ***** ****** by ****.

's ***** ****** **********

*****'* ****** ****** ******** * ********* disclaimer ********* ******* ** *** "**** report," ***** **** ** ********* **** Evolv:

IPVM Image

********* *****'* "******** ********" ** *** rational *** *** ********* *** ********** report. **** ******** ** ******* ******'* ********** **** *********** *** ********* on *****.

Evolv ******** *** ********** *********

***** **** *** ************* ******* ****** ** **'* **** report, ********* ******* * ***-********** ********* and ***** * "*********" ******** ************ with ****** ************** *** ********* ***** Express:

IPVM Image

******* ** *** ****** * ******** effect ** ********** *** **** ***** sued *** ******** *** ****** ** security ****** ********* ** *** ******.

Guns *** ****** *******

****** **********’* ****** ******, *****’* ****** ****** ***** ******* of *** ***** ** ******* *** innocuous ***** **** ** *** ******** and *** ************* ** ***** ******* at ********* ****.

*** *******, **********'* ******** ****** ***** 4 ********, ****** ** ******* ******, and ********* *****:

IPVM Image

**********'* ****** **** ***** *** ******* of ***** ******** *****:

IPVM Image

*****'* ****** ****** ***** ******* ********** with *** ********* ** **** ** knives, ******* ******* * ****** *** ferrous ***** *********.

IPVM Image

Sensitivity ******* *******

***** **** ***** *** ********** ******* have ******** *** **** *********** ******** were **** *** *** ********, *****'* omits **** ******* *** **** (*.*. A, *, * ***.).

IPVM Image

***** ********* **** **** ** ***** these *********** ******** *** *********, ***:***** ******* ******* *********** ** *******.

**********, **********'* ****** ***** *** ******** setting **** ** *** ********.

IPVM Image

Evaluator ********** *******

** ****** ******* ** ********* ********** and ******** ** ****** ***** ** omitted **** *****'* ****** ******. *** report ***** **** **** *********** ** found ** *** "**** ******" ********** by *****:

******** ********* ********** ****** *** ******** for **** ****** ****, ** **** as ******** ** *** ********** ** a *****,are ********* ** *** **** ******.

********** **** **********'* ****** ******** ******** qualitative ******** ** *********** **** ***** contextualize *** ************ *******.

Evolv: "*********" *******, ***** **** **** ****** ******

*********** * ***** *************** ********* ******:

***** *******®****** ********* ****** *******, *** *** Scores ** ******** ****** ****** ********* Categories.

*******, *** *********** ** *** *** tests **** ************* ********* *** ******* seeing *** ******** *******, *** **** performing ***** *** ** ******** ** the ******* *****.

*******, ***** **** *** ******* **** the **** ****** ** **** ********* if * *** ** ******, *********** the ******'* ******* ** ****** ** Evolv's ****** *** ****.

Evolv ****** "************"

***** ******* * *** ** **** full ****** *** ********** **** *********** NCS****** *******. ************* ** ****'* ******* ***** **** approach:

** ********* ******** ********* ************* ** the *********** ******** ******* ** ** as *********** ** ********. *******, ** part ** *** *********(*), *** ******restricted ** ******* **** ****** "************" ** *** ******** ********. While agreements require outcomes to be included in the report, solution providers can limit the data publicly shared when doing so could expose or create vulnerabilities for existing customers or undermine security processes. While our goal is not to protect the solution provider, we do prioritize the protection of venue security operations and all those attending sports and special events.

******** ** ** ****** ******* *** full ******:

*** ****strongly ********** ******** *********, *** ****** ********** ** ********* *** ***** ******* ** ****** *** **** ******. *** **** ************** *** ******** **** *** ************ used ** ******* ********** **** *******.

*******, ** *** ********* *** **** report ** *** ******, ****'* ************ aims ********.

***** ***** ** **********, **** **% over *** **** **** *********** ************* ** ********** ********** **** *******.

**********

*****’* *********** ** ********* ******* **** the ******, ***** ******* “*********” *** “top” ****** ** ************, ** *** public *** ** *** ** ******** these ******. ****** *********** **** *** public ***** *** ******.

Comments (7)

**** ** * ***** ******* ** why ** ** *** **** **** nor *************** **********. ** ** *** easy *** ************* ** **** ******** or ******* *** **** ********** ******** but ******** *********.

Agree: 7
Disagree
Informative: 5
Unhelpful
Funny

***** ** **** ********* "********* ******" on******************:

IPVM Image

Agree
Disagree
Informative: 1
Unhelpful
Funny: 1

* ******* ******** ********* ***********("***** ********") *** ******* *********** *** **** ** *********** ** the **** ***** ******. **** (********** "JP") *** **** ******** ************* ******* ***.

*******, *** ** ********* *********** ******* does *** ******** *** *********(*) ** the *******, *** **** *** ******** its *** ********* ***********.

Agree
Disagree
Informative
Unhelpful
Funny

** ********* ***********' **** ** ********** about *** *** *********** *** ** thinking ***** *********.

* **** **** **** ******* ******* advertising *** ************, ** ******** *** independence.

**** **** **** *** ****** ****** regarding *********** ** ********* **** ***** solutions ******* ** ****?

*'* *** **** *** *** **** policy (** ***) ***** **. ** some *****, *'* *** ******* *** practical * ******** *** ** *********** would **: ******** ********* *** ******* engages ** * ****** ** ********** that **** *****'* *****, *** ****** funds ******** * ****** ** ****** over ***** *** ********** ******** *** no *******.

** ** ********** ** ********** ************** ******* ****'* ****** ** ***********?

Agree
Disagree
Informative
Unhelpful
Funny

****, ** **** * ***** ****** because ** ******** **** **** **** industry ********* ***** ******, **** ***** be ** ********** *******. *** ****** is *** ** **** *** *********** in *** ********* ** ***** (******* long *** *****). **'** ******** ******* it ** *** **** ******. **** said * *** ************* ****** ** here.

*** *** ******, * **** ***** owned *** ******** ** *** ******* we ******* (*** **** * **** shorted ** **** *** ***** ********* instrument ******* ** *** ******* ** cover). *** ** ** ******* ** Evolv ********, ******* ****, *** *** myself **** *** ********* ** ********** stake ** *****. * **** *** checked **** ******** *** ***** ** IPVM *** * ** ************** **** concerned **** ****** ****** *** **** direct ******* **** ********* ** **********.

****, ***** ** *** *** ** investment ******* **'* *** ********* **** I ** ************ ********** ** *****, in ******** ** *** ******* *** give ***** **** **** *******.

Agree: 1
Disagree
Informative: 2
Unhelpful
Funny

* **** *** ******* **** ******** who ***** ** **** *** * am ************** **** ********* **** ****** people *** **** ****** ******* **** editorial ** **********.

* ** *** *** **** *** owned ******** ** *** ********* **** covers.

Agree: 1
Disagree
Informative: 2
Unhelpful
Funny

**** ** **** * *** ******* about ** * ******** ****** ***** these *******. ** ******* **** *** had ** ****** *** ***** ******** side ** ***** ***, **** "**********" is *** ***** *** ***.

Agree
Disagree
Informative: 2
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports